1361 – 1370 of 1515
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Evaluation of plasma A beta 40 and A beta 42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment Response
- Contribution to journal › Debate/Note/Editorial
-
Mark
Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years.
- Contribution to journal › Article
-
Mark
Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.
- Contribution to journal › Article
-
Mark
Evaluation of CSF Biomarkers as Predictors of Alzheimer's Disease: A Clinical Follow-Up Study of 4.7 Years.
- Contribution to journal › Article
-
Mark
A Quick Test of cognitive speed is sensitive in detecting early treatment response in Alzheimer's disease
- Contribution to journal › Article
-
Mark
CSF biomarkers predict a more malignant outcome in Alzheimer disease.
- Contribution to journal › Article
-
Mark
Plasma concentration of galantamine - influence of dose and body mass index in Alzheimer’s disease.
(2010) 11th International Geneva/Springfield Symposium on Advances in Alzheimer Therapy
- Contribution to conference › Poster
-
Mark
An enzyme activity as a potential biomarker for Alzheimer's disease.
(2010) Alzheimer's Association International Conference on Alzheimer's Disease 2010 In Alzheimer's & Dementia 6(4). p.497-498
- Contribution to journal › Published meeting abstract
-
Mark
Convergence of chromogranin and amyloid metabolism in the brain.
(2010) Alzheimer's Association International Conference on Alzheimer's Disease 2010 In Alzheimer's & Dementia 6(4). p.511-511
- Contribution to journal › Published meeting abstract
-
Mark
Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.
- Contribution to journal › Article
